Castle Biosciences CSTL
NASDAQ CSTL
$34.44 +1.28 (+3.88%)
As of: Oct 21, 2026 · 11:13 AM EDT

Castle Biosciences (CSTL) Notes Payables (2019)

Updated

Castle Biosciences' Notes Payables was $4.43 million in Q2 2019.

Analysis

Castle Biosciences (CSTL) Notes Payables (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 102.01 Bn 98.02 Bn -
2 Natera 59.89 Bn 55.57 Bn 485.19 Mn
3 Quest Diagnostics 26.41 Bn 24.54 Bn 1.03 Bn
4 Labcorp Holdings 26.36 Bn 24.10 Bn 1.11 Bn
5 Tenet Healthcare 22.61 Bn 11.62 Bn -
6 Guardant Health 22.43 Bn 18.49 Bn 219.03 Mn
7 BrightSpring Health Services 12.94 Bn 11.28 Bn 492.75 Mn
8 Fresenius Medical Care AG 12.59 Bn 4.55 Bn 1.52 Bn
9 Tempus AI 12.27 Bn 9.30 Bn 246.50 Mn
10 Castle Biosciences 1.05 Bn -66.88 Mn 79.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 4.43 Mn
API Access

Castle Biosciences Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=CSTL&period=max&api_key=YOUR_API_KEY